Literature DB >> 3664429

Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type.

C Micheau1, H Boussen, J Klijanienko, E Cvitkovic, S Stosic, G Schwaab, F Eschwege, J P Armand.   

Abstract

Bone marrow involvement was found in 21 of 56 patients with undifferentiated carcinoma of the nasopharyngeal type UCNT whose nasopharyngeal and bone marrow biopsies were available. Radiotherapy and chemotherapy (cisplatin, 5-fluorouracil and bleomycin) were given because of distant metastases. The microscopic aspects of bone invasion were investigated and were classified into three subtypes osteolytic, osteosclerotic and mixed type. The UCNT patients population was 10 years younger than that studied previously. Both the extent of the primary tumor (T) and cervical lymph node status (N) exerted an influence on the probability of metastases developing. Chemotherapy given to patients must be improved because UCNT with bone metastases is a disease with a poor prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3664429     DOI: 10.1002/1097-0142(19871115)60:10<2459::aid-cncr2820601019>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Recent advances in bone marrow scanning.

Authors:  S N Reske
Journal:  Eur J Nucl Med       Date:  1991

2.  Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma.

Authors:  C-K Toh; D Heng; Y-K Ong; S-S Leong; J Wee; E-H Tan
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

3.  Skeletal scintigraphy as an important complement for detecting bone metastasis from nasopharyngeal carcinoma.

Authors:  Wei-Jheng Yen; Chih-Ting Liu; Ya-Min Chi; Chin-Chuan Chang
Journal:  J Int Med Res       Date:  2022-08       Impact factor: 1.573

4.  Differential baseline and response profile to IFN-gamma gene transduction of IL-6/IL-6 receptor-alpha secretion discriminate primary tumors versus bone marrow metastases of nasopharyngeal carcinomas in culture.

Authors:  Andy Shau-Bin Chou; Hsin-Yi Wang; Hung-Chang Chen; Ming-Hsiu Tsai; Cheng-Keng Chuang; Shuen-Kuei Liao
Journal:  BMC Cancer       Date:  2009-06-05       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.